| 基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
|---|---|---|---|---|---|
| LZTS1 | 0 | 0 | |||
| LZTR1 | 神经鞘瘤病 | 1 | 1 | ||
| LYRM9 | 0 | 0 | |||
| LYN | 慢性髓系白血病 | 阿昔替尼,达沙替尼, | 1 | 2 | |
| LTK | 0 | 0 | |||
| LSMEM1 | 0 | 0 | |||
| LRRTM4 | 0 | 0 | |||
| LRRK2 | 0 | 0 | |||
| LRRK1 | 0 | 0 | |||
| LRRIQ3 | 0 | 0 | |||
| LRRFIP2 | 0 | 0 | |||
| LRRC7 | 0 | 0 | |||
| LRRC4C | 0 | 0 | |||
| LRRC34 | 0 | 0 | |||
| LRP6 | 0 | 0 | |||
| LRP5 | 0 | 0 | |||
| LRP4 | 0 | 0 | |||
| LRP2 | 0 | 0 | |||
| LRP1B | 多形性胶质母细胞瘤 | 多柔比星, | 2 | 2 | |
| LRP1 | 0 | 0 | |||
| LRIG3 | 0 | 0 | |||
| LRFN5 | 0 | 0 | |||
| LPP | 0 | 0 | |||
| LPL | 0 | 0 | |||
| LONRF3 | 0 | 0 | |||
| LMO1 | 0 | 0 | |||
| LIMK1 | 0 | 0 | |||
| LIG4 | 0 | 0 | |||
| LIG3 | 0 | 0 | |||
| LIFR | 0 | 0 | |||
| LHCGR | 0 | 0 | |||
| LGALS8 | 0 | 0 | |||
| LEPR | 脑膜瘤 | 1 | 1 | ||
| LEF1 | 0 | 0 | |||
| LDLR | 0 | 0 | |||
| LCP1 | 0 | 0 | |||
| LCK | 0 | 0 | |||
| LATS2 | 0 | 0 | |||
| LATS1 | 0 | 0 | |||
| LASP1 | 0 | 0 | |||
| LAMA3 | 0 | 0 | |||
| LAMA2 | 0 | 0 | |||
| LAG3 | 雌激素受体阴性乳腺癌 | 1 | 1 | ||
| L3MBTL1 | 0 | 0 |
Copyright © 2020 基因医生
京ICP备13051264号-65 
京公网安备
11010802036025号